GENinCode (LON:GENI) Stock Price Down 4.8% – Should You Sell?

Shares of GENinCode Plc (LON:GENI) traded down 4.8% during mid-day trading on Tuesday . The company traded as low as GBX 1.02 and last traded at GBX 1.07. 4,913,231 shares traded hands during mid-day trading, a decline of 3% from the average session volume of 5,059,487 shares. The stock had previously closed at GBX 1.13.

GENinCode Stock Down 4.8%

The company has a debt-to-equity ratio of 7.17, a current ratio of 2.80 and a quick ratio of 15.89. The stock has a market cap of £7.77 million, a price-to-earnings ratio of -0.46 and a beta of 0.62. The firm has a 50 day simple moving average of GBX 1.32 and a two-hundred day simple moving average of GBX 2.29.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.